EORTC in the times of COVID-19
EORTC in times of COVID-19 [...]
The JCOG-EORTC clinical trials symposium 15 February 2020
The JCOG-EORTC symposium 15 February 2020 EORTC-JCOG [...]
EORTC’s STRASS II trial in retroperitoneal sarcoma receives support by the Anticancer Fund
EORTC’s STRASS II trial in retroperitoneal sarcoma receives support by the [...]
SPECTA updates
SPECTA updates SPECTA for Molecular [...]
WBA 2019 CSR Report Launch
WBA 2019 CSR Report Launch In [...]
Cancer patients own reporting of their quality of life can be important in predicting the outcome of their disease, says EORTC.
Cancer patients own reporting of their quality of life [...]
Collaboration with ESTRO to maximise the benefits of radiation oncology
A collaboration to maximise the benefits of radiation oncology [...]
EORTC: The future of cancer therapy
EORTC: The future of cancer therapy [...]
POLICY ACTION: Affordable health care that leaves no one behind – EORTC manifesto
POLICY ACTION: Affordable health care that leaves no one behind [...]
EORTC Quality of Life meeting in Brussels
EORTC Quality of Life meeting in Brussels [...]
